Navigation Links
Managing specialized microbes to clean stubborn chemicals from the environment
Date:6/26/2014

e the nature of this stalling during the TCE-to-ethene reaction. Earlier studies had proposed that Dehalococcoides at a given bioremediation site lacked the necessary machinery required to complete the full breakdown of TCE into ethene. An alternate explanation suggested that Dehalococcoides was somehow inhibited during the process.

Delgado's work points to another explanation and a plausible means for rectifying the stalling problem. Dehalococcoides require hydrogen (H2) as an electron donor for their respiratory cycle. The current experiments proved that in some cases, Dehalococcoides are out-competed for hydrogen by a variety of other microorganisms present in the soil or sediment.

Samples of soil and sediment from three sites (Romania, Puerto Rico and South Carolina) were examined. The first two samples were uncontaminated while the third was extracted from a military base in Parris Island, South Carolina a site contaminated with PCE, a chlorinated chemical similar to TCE.

All three samples were used in microcosm studies where general environmental conditions of a given site are replicated in a sample bottle and remediation effects can be acutely analyzed. The studies demonstrated that sites bearing wide microbial diversity (such as the uncontaminated Romanian and Puerto Rican samples) contained large numbers of bacteria capable of out-competing Dehalococcoides for essential hydrogen, thereby causing the breakdown of chlorinated chemicals to stall at the cis-DCE phase.

In the case of the contaminated sample from South Carolina, Dehalococcoides was successful in the full reduction of chlorinated chemical to ethene. The authors speculate that the toxic contaminant in the sediment likely acted to limit microbial diversity, allowing Dehalococcoides better access to hydrogen.

In the Romanian and Puerto Rican soil samples, conditions for Dehalococcoides to thrive were
'/>"/>

Contact: Joseph Caspermeyer
Joseph.Caspermeyer@asu.edu
Arizona State University
Source:Eurekalert  

Page: 1 2 3 4

Related biology news :

1. Managing renewables intelligently
2. Internists must play a larger role in managing menopausal symptoms
3. Managing Type 1 diabetes as an adolescent
4. Managing waters shared across national boundaries: Treasury of papers helps capture 20 years of lessons
5. Research examines new methods for managing digestive health
6. Managing biodiversity data from local government
7. NIST chip produces and detects specialized gas for biomedical analysis
8. AegisCare Offers Specialized Home Health Care for Dementia and Alzheimers Patients
9. First fossil bird with teeth specialized for tough diet
10. Preclinical studies use specialized ultrasound to detect presence of cancer
11. Dinosaur fossil: Even specialized predators didnt turn down free meals
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Managing specialized microbes to clean stubborn chemicals from the environment
(Date:11/21/2014)... DALLAS , November 18, 2014 ... Security Systems Market by Systems (Video, RFID, Access Control, ... (SEZ, Factories, Hotels, Banks, Government), Component Service Geography - ... Security Systems Market is projected to be around $25 ... Billion by 2020, growing at a CAGR of 8.69%. ...
(Date:11/21/2014)... Nov. 20, 2014   Atmel® Corporation (NASDAQ: ... (MCU) and touch technology solutions, today launched the industry,s ... with the widest V cc range from 1.7V ... and faster I 2 C bus communication speeds, and ... memory making them ideal for consumer, industrial, computer, and ...
(Date:11/18/2014)... Nov. 18, 2014   EyeLock Inc. , ... and MorphoTrust USA (Safran), a leading ... announced a strategic partnership to offer comprehensive biometric ... administration (MVA), airport screening and financial services markets. ... MorphoTrust serves consumers through a nationwide network of ...
Breaking Biology News(10 mins):Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3
... we thought that gene expression was modulated only by transcription ... could be regulated by the RISC complex (siRNA-mediated degradation via ... level is even more complex than we first imaginated... ... requirement for using a weapon or tool is finding it. ...
... five mammals living on Earth is a bat, yet their ... record and conflicting or incomplete theories about their origins and ... Riverside Biology Professor Mark Springer, has published a paper in ... molecular biology and the fossil data to fill in many ...
... breast cancer treated with radical mastectomy and adjuvant chemotherapy, ... outcomes with few long-term toxic effects, according to a ... the January 19 issue of the Journal of the ... therapy trial was designed to determine the effect on ...
Cached Biology News:A new mechanism of regulating RNA degradation 2A new mechanism of regulating RNA degradation 3Molecular biology fills gaps in knowledge of bat evolution 2Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down 2
(Date:12/15/2014)... , Dec. 15, 2014  GlassesOff Inc. (OTCBB: ... Bar-Gil as an independent director of the Company,s ... of AeroScout and served as its CEO until its ... 2012, a $240 million transaction. Recognized as the inventor ... Bar-Gil,s leadership, AeroScout provided Wi-Fi -based RFID solutions focused ...
(Date:12/13/2014)... Rockville, Maryland (PRWEB) December 12, 2014 ... Maryland, today announced its new name: Therabron Therapeutics ... words therapy and bronchioles (a type of structure in ... incorporating the company’s mission to develop novel protein therapeutics ... board of directors decided to change the name to ...
(Date:12/13/2014)... York (PRWEB) December 13, 2014 QuickSTAT ... global network and Cold Chain capabilities, and is delighted ... in Paris, France, to serve Life Science clients in ... equipped with a controlled-ambient warehouse, will provide 24/7 transportation ... vaccines and investigational drugs, patient-clinical specimens, API, following IATA ...
(Date:12/12/2014)... InSphero AG, the world’s leading provider of 3D ... data presented recently by Genentech (South San Francisco, CA) ... model system for assessment of liver toxicity. ... Analysis and Screening Technologies (FAST) Congress summarized a ... 3D InSight™ Human Liver Microtissues to 42 known ...
Breaking Biology Technology:AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2Quick Opens Office in France to Serve Life Science Community In France and Neighboring French-Speaking Countries 2Enhanced Sensitivity of InSphero 3D Liver Microtissues Highlighted at Annual Screening Congress 2Enhanced Sensitivity of InSphero 3D Liver Microtissues Highlighted at Annual Screening Congress 3
... ... ... ... ...
... ... ... ... ...
... leap forward in the understanding of how specific types of ... of scientists has succeeded in mapping the entire network of ... network, indicating which factors can combine to determine cell fate, ... journal Cell . Transcription factors (TFs) are proteins ...
Cached Biology Technology:LifeNet Health and Soluble Systems Announce Partnership to Launch TheraSkin(TM) 2LifeNet Health and Soluble Systems Announce Partnership to Launch TheraSkin(TM) 3LifeNet Health and Soluble Systems Announce Partnership to Launch TheraSkin(TM) 4LifeNet Health and Soluble Systems Announce Partnership to Launch TheraSkin(TM) 5China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 2China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 3China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 4China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 5China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 6China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 7China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 8China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 9China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 10China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 11China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 12China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 13China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 14China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 15China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 16China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 17China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 18China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 19China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 20China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010 21Researchers create atlas of transcription factor combinations 2
... and SYBR Safe DNA Gel Stain combo offers these ... buying these same products separately ... bromide Eliminates risks to ... and RNA fragments from 100 bp to >30 kb. ...
...
Sterile detoxified 10% bovine serum albumin (BSA) in Iscoves MDM. This BSA has been selected to support the optimal colony growth of human hematopoietic progenitor cells in methylcellulose-based medi...
... A full-featured high-performance ICP-MS system designed for ... interface, Omega II off-axis ion lens, true ... 7500a can handle the widest range of ... the 7500a now includes as standard Agilents ...
Biology Products: